LifeMD, Inc.
LFMD
$4.28
-$0.11-2.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.42% | 754.17% | 12.95% | 17.69% | 15.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.42% | 754.17% | 12.95% | 17.69% | 15.28% |
| Cost of Revenue | -27.17% | -11.42% | 47.76% | 47.88% | 76.87% |
| Gross Profit | 3.48% | 3,205.70% | 9.34% | 14.45% | 8.11% |
| SG&A Expenses | 21.20% | 1,175.41% | 3.02% | 6.82% | -3.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 39.94% | 50.94% | 43.93% | 58.57% | -3.27% |
| Total Operating Expenses | 13.49% | 318.70% | 8.51% | 12.35% | 3.49% |
| Operating Income | -655.61% | 81.61% | 50.72% | 52.64% | 80.85% |
| Income Before Tax | -439.24% | 83.68% | 25.63% | 44.07% | 75.25% |
| Income Tax Expenses | -- | -96.20% | -27.27% | -- | -- |
| Earnings from Continuing Operations | -439.24% | 84.33% | 25.71% | 44.07% | 75.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 106.64% | -292.66% | -104.41% | -345.39% |
| Net Income | -4,727.31% | 504.24% | 18.29% | 36.79% | 97.28% |
| EBIT | -655.61% | 81.61% | 50.72% | 52.64% | 80.85% |
| EBITDA | -744.14% | 88.00% | 60.07% | 59.78% | 82.60% |
| EPS Basic | -813.90% | 403.85% | 23.20% | 36.69% | 88.40% |
| Normalized Basic EPS | -223.48% | 86.80% | 44.98% | 37.53% | 66.76% |
| EPS Diluted | -813.90% | 392.78% | 23.08% | 37.27% | 88.40% |
| Normalized Diluted EPS | -223.48% | 86.80% | 44.98% | 37.53% | 66.76% |
| Average Basic Shares Outstanding | 9.74% | 13.54% | 9.86% | 7.55% | 9.92% |
| Average Diluted Shares Outstanding | 9.74% | 13.54% | 9.86% | 7.55% | 9.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.98% | 1.27% | -0.22% | -0.58% | -35.83% |